Clinical Trial

Percutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Hypertension After Transcatheter Mitral Valve Edge-to-Edge Repair (M-TEER): A Prospective Cohort Study

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
this study aims to investigate the efficacy and safety of PADN therapy compared with standard medical therapy in patients diagnosed with pulmonary hypertension after M-TEER, thereby providing evidence for clinical treatment decision-making
Trial Details
NCT Number NCT07662655
Lead Sponsor Xiamen Cardiovascular Hospital, Xiamen University
Conditions Pulmonary Hypertension, Pulmonary Hypertension Associated With HFpEF
Enrollment 60 participants
Start Date 2026-06-06
Primary Completion 2028-05-31 (estimated)
Study Completion 2028-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-23